Autosomal dominant Parkinson disease 8: genes and variants
Explore variant evidence for Autosomal dominant Parkinson disease 8 across 3 analyzed proteins (LRRK2, SNCA, PRKN). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 419 variants of uncertain significance and 33 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant Parkinson disease 8
LRRK2: Leucine-rich repeat serine/threonine-protein kinase 2
Its kinase and GTPase activities regulate Rab proteins, vesicle trafficking, lysosomal function, and cellular stress responses. Gain-of-function variants, especially G2019S, are among the most common genetic causes of autosomal dominant Parkinson disease.
7 ClinVar pathogenic / likely pathogenic and 451 uncertain variants in LRRK2 have source records linked to Autosomal dominant Parkinson disease 8. Association strength is not clinical gene validity.
SNCA: Alpha-synuclein
Alpha-synuclein is a neuronal protein that supports synaptic-vesicle trafficking, priming, and neurotransmitter release. Misfolded or aggregated alpha-synuclein is a defining feature of Parkinson disease and Lewy-body disorders.
3 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SNCA have source records linked to Autosomal dominant Parkinson disease 8. Association strength is not clinical gene validity.
PRKN: E3 ubiquitin-protein ligase parkin
Its parkin ubiquitin-ligase activity marks damaged mitochondrial proteins after PINK1 activation and helps eliminate dysfunctional mitochondria through mitophagy. Biallelic loss-of-function variants are a major cause of autosomal recessive juvenile or early-onset Parkinson disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PRKN have source records linked to Autosomal dominant Parkinson disease 8. Association strength is not clinical gene validity.
Where Autosomal dominant Parkinson disease 8 variants cluster
- LRRK2 Roc (positions 1328–1511): 4 of 7 ClinVar pathogenic / likely pathogenic variants, 7.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant Parkinson disease 8
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LRRK2 R1441C | 1441 | Roc | Pathogenic / likely pathogenic (★★) |
| LRRK2 R1441G | 1441 | Roc | Pathogenic / likely pathogenic (★★) |
| LRRK2 R1441H | 1441 | Roc | Pathogenic / likely pathogenic (★★) |
| PRKN M1T | 1 | Ubiquitin-like | Pathogenic / likely pathogenic (★★) |
| LRRK2 I2020T | 2020 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| SNCA A53T | 53 | 3 | Pathogenic / likely pathogenic (★★) |
| LRRK2 R1441S | 1441 | Roc | Pathogenic / likely pathogenic (★) |
| SNCA A30P | 30 | 1 | Pathogenic / likely pathogenic (★) |
| SNCA E46K | 46 | 3 | Pathogenic / likely pathogenic (★) |
| LRRK2 I1122V | 1122 | LRR 6 | Pathogenic / likely pathogenic |
| LRRK2 Y1699C | 1699 | COR | Pathogenic / likely pathogenic |
Which prediction tools work for Autosomal dominant Parkinson disease 8
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 83 out of 100
- AlphaMissense: 81 out of 100
- PolyPhen-2: 73 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 64 out of 100
Same protein, different disease
- Autosomal recessive juvenile Parkinson disease 2 also has ClinVar records linked to PRKN variants; they fall mostly in different places as the Autosomal dominant Parkinson disease 8 variants (15 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to PRKN variants; they fall mostly in different places as the Autosomal dominant Parkinson disease 8 variants (5 pathogenic / likely pathogenic).
- Lung cancer also has ClinVar records linked to PRKN variants; they fall mostly in different places as the Autosomal dominant Parkinson disease 8 variants (4 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant Parkinson disease 8
- Parkinson disease, also linked to LRRK2, PRKN and SNCA
- Young-onset Parkinson disease, also linked to LRRK2, PRKN and SNCA
- Ovarian cancer, also linked to PRKN
- Autosomal recessive juvenile Parkinson disease 2, also linked to PRKN
- Ovarian neoplasm, also linked to PRKN
- Lung cancer, also linked to PRKN
- Lewy body dementia, also linked to SNCA
Frequently asked questions
Which genes have records linked to Autosomal dominant Parkinson disease 8?
This view contains 3 analyzed proteins: LRRK2, SNCA, PRKN. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 419 variants of uncertain significance and 33 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 524 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center